FDA panel backs Acadia drug for psychosis linked to Parkinson's

(Reuters) - An advisory panel to the U.S. Food and Drug Administration recommended an approval for Acadia Pharmaceuticals Inc's drug for psychosis related to Parkinson's disease.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro